Escalon Medical (OTCMKTS:ESMC) Stock Price Crosses Above 50 Day Moving Average – What’s Next?

Escalon Medical Corp. (OTCMKTS:ESMC – Get Free Report) shares crossed above its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $0.17 and traded as high as $0.17. Escalon Medical shares last traded at $0.17, with a volume of 2,000 shares traded.

Escalon Medical Price Performance

The firm’s 50-day moving average price is $0.17 and its 200-day moving average price is $0.18. The company has a market cap of $1.26 million, a price-to-earnings ratio of 0.65 and a beta of 0.51. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.94 and a quick ratio of 2.21.

Escalon Medical (OTCMKTS:ESMC – Get Free Report) last posted its earnings results on Tuesday, October 13th. The medical equipment provider reported $0.12 earnings per share for the quarter. Escalon Medical had a net margin of 31.50% and a return on equity of 65.44%. The business had revenue of $3.86 million for the quarter.

Escalon Medical Company Profile

(Get Free Report)

Escalon Medical Corp. is a medical-device company focused on products for the ophthalmic surgical market. The company develops, manufactures and markets devices and related products used by eye-care professionals, particularly in procedures involving the retina and vitreous.

Its product offerings have included ophthalmic surgical instruments, delivery systems and products used in retinal surgery, such as intraocular gases, silicone oils and other retinal tamponade materials. These products are designed to support procedures for treating retinal detachments and other serious eye conditions.

Escalon Medical has historically served ophthalmic surgeons and medical institutions through markets in the United States and internationally.

Featured Articles

Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.